Weiner Russell J reported grant involving 226.7613 derivative units of CLOROX CO DE at $0.00 for $0 on Aug 28, 2026

Grant
Form 4 code A. Grant, award, or other acquisition under Rule 16b-3(d).
Director
DIR
Filed Oct 2, 2026

Facts from the filing

Form 4 · Derivative, table II
Disclosed value
$0Shares × reported price
Shares traded
226.7613Deferred Stock Units
Price per share
$0.00Reported price. Read footnotes for ranges.
% of reported position traded
UnavailableThis security and ownership context
Holdings after
18,826.6314Direct
Trade date
Aug 28, 2026Grant
Filed
Oct 2, 2026, 4:16 PM ET35-day reporting delay
Accession
0001225208-26-008111Code A · Transaction 234622
How reported position traded is calculated

Not calculated for derivative securities.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Other trades in this filing

Trade dateActivitySharesPriceValueDetails
Sep 30, 2026Grant416.6152$0.00$0Trade 234623
2 transaction rows in this filing. Joint filers share the same rows.

Filing warnings

Notes recorded with this filing
1 warning
delayed filingThe filing was reported 35 calendar days after the transaction date.

CLX price since this filing

Daily closing prices, with the filing date and available return windows. Return methodology
CLX · Daily closing priceDaily price data is pending. The chart appears when valid daily closes are available.
Filing dateReturn windows appear as prices become available.
Pre-filing1mo ago +20%1w ago +33%1d ago +32%
Returns since7d +4.2%30d +9.4%90d180d1y

Footnotes in full

F1: 1-for-1 F2: Deferred Stock Units acquired through dividend reinvestment during the fiscal year pursuant to the Independent Directors' Deferred Compensation Plan. F3: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. F4: Receipt of Deferred Stock Units in lieu of receipt of quarterly director's fees.